A couple of weeks ago Avi Roy, alongside Nathan Cheng & Laura Minquini, hosted the Longevity Panel discussion, which assembled some of the biggest scientists in the field currently working on reversing aging.
This discussion was intended to illuminate how they are approaching longevity and to know if we are any closer in achieving it.
The talk was split into two sections: the first being open discussion guided by questions from the hosts. The talk was then opened up to the floor, allowing audience questions. Part 1 will provide the transcript from the first section of the Longevity Panel. Enjoy!
The hosts:
-
Laura Minquini – the founder of MYKIGAI, a DTC longevity platform dedicated to the education, vetted curation and management tools for people to get on board with longevity as a lifestyle. Having spent most of her career in trend forecasting and branding design and fashion products she sees the potential of longevity becoming the next big consumer category empowering people to take their health in their own hands.
-
Avi Roy – a biomedical scientist and entrepreneur based in Oxford. He advises and funds startups in the health and longevity space in North America, the EU, and India. He also work with governments to develop and refine policies that enable the longevity infrastructure.
-
Nathan Cheng – the founder of the Longevity Marketcap Newsletter, a once a week roundup of the developments in the longevity biotech industry. He is also the founder of Longevity List — a website where you can find jobs, companies, and investors in the longevity biotech industry.
The panel:
-
Alexandra Stolzing – the head of research at SENS research foundation and Professor at Loughborough University. Her research focuses around the amelioration of the hallmarks of aging.
-
David Sinclair – a Professor of genetics and co-director of the Paul F. Glenn centre for the biology of aging at Harvard medical school. Devid is also the author of ‘Lifespan‘, and his research focuses on understanding and slowing the pace of aging through a variety of approaches.
-
Liz Parrish – the founder and CEO of Bioviva sciences. Liz’s focus is the advancement of gene therapy for the purpose of extending healthy lifespan in humans.
-
Aubrey de Grey – the chief scientist officer and co-founder of the SENS research foundation. Aubrey is a biomedical gerontologist, author of ‘Ending Aging‘ and one of the longest proponents to study the field of longevity.
-
David Gobel – the co-founder and CEO of Methuselah foundation. David’s focus is establishing and supporting research, breakthrough technologies, and regenerative medicine.
-
Joao Pedro de Magalhaes – a microbiologist and Professor at the University of Liverpool. The goal of Joao’s work is to understand the genetic cellular and molecular mechanisms of aging across all organisms.
-
Jean Hebert – Associate Professor in the department of genetics at the Albert Einstein college of medicine, and author Replacing Aging. Jean spends his time devising methods of cell replacement for the adult neocortex, where its cells are lost due to damage or age-related to degeneration.
-
Greg Fahy – the vice president and chief scientist officers of 21st century medicine and founder of Intervene Immune. Greg is also a cryobiologist, biogerontologist, and businessman based in California. His research focuses on organ cryopreservation by vitrification.
Part 1
Part 2
Transcripts:
Part 1: Longevity Panel - The Scientists working on Reversing Aging | Part 1 - Gowing Life
Part 2: Longevity Panel - The Scientists working on Reversing Aging | Part 2 - Gowing Life